- GST rate cut triggers rally in footwear, paint, consumer durable stocks
- SC says there can't be complete ban on protests at Jantar Mantar in Delhi
- Asian Paints, Havells India, Bata India, Bajaj Finance, HEG hit new high
- Earned capital gains? Expert views on 5 things to keep in mind
- Corrected: Wall Street braces for tariff fallout as S&P 500 companies report
- Sprint queen Hima Das: Is she the next big thing in brand endorsements?
- South Indian Bank tanks 18% on weak Q1 results
- The story behind Google's secret offer to settle EU's Android probe
- Two wheeler stocks trade weak; Hero MotoCorp, TVS Motor hit 52-week low
KDL Biotech Ltd.
|BSE: 532291||Sector: Health care|
|NSE: KOPDRUGS||ISIN Code: INE746A01010|
|BSE 00:00 | 02 Mar||KDL Biotech Ltd|
|NSE 05:30 | 01 Jan||KDL Biotech Ltd|
KDL Biotech Ltd. (KOPDRUGS) - Peer Group